Ortolani S - Search Results

1

Biological characterization of refractory anemia with excess of blasts.

Maiolo AT, Foa P, Pagetti D, Baldini L, Mozzana R, Ortolani S, Colantoni A, Lombardi L, Lavezzi AM, Polli EE. Maiolo AT, et al. Among authors: ortolani s. Haematologica. 1987 Nov-Dec;72(6 Suppl):126-9. Haematologica. 1987. PMID: 3127288 Review. No abstract available.

2

1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosis.

Foa P, Maiolo AT, Cortellaro M, Ortolani S, Pogliani E, Deliliers GL, Iurlo A, Zocchi L, Gualdoni A, Polli E. Foa P, et al. Among authors: ortolani s. Haematologica. 1990 May-Jun;75(3):294-5. Haematologica. 1990. PMID: 2227630

3

[Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)].

Vigo P, Ortolani S, Soldati L, Girardello R, Fleischmann L, Polli EE. Vigo P, et al. Among authors: ortolani s. Haematologica. 1981 Oct;66(5):656-66. Haematologica. 1981. PMID: 6796473 Italian. No abstract available.

4

Immunoreactive calcitonin: a tumor marker for myelogenous leukemias.

Foa P, Ortolani S, Pogliani EM, Iurlo A, Gualdoni A, Maiolo AT, Polli EE. Foa P, et al. Among authors: ortolani s. Int J Biol Markers. 1990 Jan-Mar;5(1):27-30. doi: 10.1177/172460089000500105. Int J Biol Markers. 1990. PMID: 2230349

5

1,25-Dihydroxyvitamin D3 and myeloproliferative syndromes.

Foa P, Cortellaro M, Ortolani S, Pogliani E, Iurlo A, Zocchi L, Gualdoni A, Maiolo AT, Polli EE. Foa P, et al. Among authors: ortolani s. Am J Hematol. 1990 Mar;33(3):222. doi: 10.1002/ajh.2830330313. Am J Hematol. 1990. PMID: 2301382 No abstract available.

6

Influence of body parameters on female peak bone mass and bone loss.

Ortolani S, Trevisan C, Bianchi ML, Gandolini G, Cherubini R, Polli EE. Ortolani S, et al. Osteoporos Int. 1993;3 Suppl 1:61-6. doi: 10.1007/BF01621866. Osteoporos Int. 1993. PMID: 8461579 No abstract available.

7

Basal plasma levels of calcitonin and bone mineral mass in normal and uremic women. Effect of menopause.

Corghi E, Ortolani S, Bianchi ML, Favini P, Vigo P, Polli EE. Corghi E, et al. Among authors: ortolani s. Biomed Pharmacother. 1984;38(5):263-5. Biomed Pharmacother. 1984. PMID: 6525424

8

Plasma immunoreactive N-terminal parathyroid hormone and cyclic AMP and cyclic GMP urinary levels in man after I. M. administration of two different doses of porcine calcitonin.

Vigo PL, Milhaud G, Peracchi M, Girardello R, Ortolani S, Polli EE. Vigo PL, et al. Among authors: ortolani s. Biomedicine. 1980 Dec;33(8):255-9. Biomedicine. 1980. PMID: 6260260 Clinical Trial.

9

[Therapy of senile osteoporosis with porcine extraction calcitonin in paraphysiological doses].

Vigo P, Girardello R, Soldati L, Favini P, Ortolani S, Polli EE. Vigo P, et al. Among authors: ortolani s. Recenti Prog Med. 1979 Jun;66(6):607-26. Recenti Prog Med. 1979. PMID: 398571 Review. Italian. No abstract available.

10

Age, time since menopause, and body parameters as determinants of female spinal bone mass: a mathematical model.

Trevisan C, Ortolani S, Bianchi ML, Caraceni MP, Ulivieri FM, Gandolini G, Polli EE. Trevisan C, et al. Among authors: ortolani s. Calcif Tissue Int. 1991 Jul;49(1):1-5. doi: 10.1007/BF02555894. Calcif Tissue Int. 1991. PMID: 1893289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters